Do you have questions about the recent changes announced by Ultragenyx to their CTD clinical development program? ACD is hosting a virtual town hall event on December 17th from 2-3 pm PT with Ultragenyx representatives to answer your questions. We will hear from the following Ultragenyx team members:

• Marcus Andrews, PhD, Senior Director, Non-Clinical Sciences, Pharmacology/Toxicology
• Hilary Beggs, PhD, Executive Director, Program Team Leader
• Melanie Brandabur, MD, Senior Medical Director, Global Clinical Development

Register and submit your questions here.